Elizabeth Anderson

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.

J. Bowsher, R. Coleman, D. Bigner, 2004, Blood.

Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma

D. Niedzwiecki, C. Decastro, D. Rizzieri, 2004, Cancer.

Phase 1 trial study of 131 I-labeled chimeric 81 C 6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

J. Bowsher, R. Coleman, D. Bigner, 2004 .

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

H. Hurwitz, R. Riedel, J. Bendell, 2012, Cancer Chemotherapy and Pharmacology.

A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer

J. Herndon, J. Crawford, J. Garst, 2006, Clinical drug investigation.

Clofarabine Produces Durable Remissions in Older Patients with AML with Unfavorable Prognostic Factors and Multiple Comorbidities.

J. Gabrilove, H. Kantarjian, T. Kovacsovics, 2009 .